Literature DB >> 15269454

Impact of stage differentiation on diagnosis of toxoplasmosis.

Uwe Gross1, Mathias Holpert, Stefan Goebel.   

Abstract

Within its intermediate host, such as man, the protozoan parasite Toxoplasma gondii interconverts between tachyzoites and bradyzoites. The replicative tachyzoite stage is thought to be responsible for acute/active infection and expresses immunodominant antigens thereby inducing a strong cellular immune response, which vice versa triggers the differentiation process into dormant and immunologically weak cyst stages. The immunodominance of tachyzoites is also responsible for the induction of a strong humoral immune response leading to the formation of antibodies specifically directed against tachyzoite antigens. In contrast, the bradyzoite stage which is associated with inactive/chronic infection, seems not to be a strong inducer of specific antibodies. However, since the humoral antibody response is also directed against antigens that are expressed in both stages, serodiagnosis cannot always adequately discriminate between active and inactive/chronic infection. This short review focuses on the impact of stage differentiation and discusses the potential of stage-specifically expressed antigens that might be useful in a recombinant form in order to improve future serodiagnostical approaches.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15269454

Source DB:  PubMed          Journal:  Ann Ist Super Sanita        ISSN: 0021-2571            Impact factor:   1.663


  8 in total

1.  Use of MAG1 recombinant antigen for diagnosis of Toxoplasma gondii infection in humans.

Authors:  Lucyna Holec; Elzbieta Hiszczyńska-Sawicka; Artur Gasior; Anna Brillowska-Dabrowska; Józef Kur
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

2.  Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity.

Authors:  Marijo S Roiko; Kaice LaFavers; Diane Leland; Gustavo Arrizabalaga
Journal:  Int J Parasitol       Date:  2017-11-21       Impact factor: 3.981

3.  Identification of Toxoplasma gondii antigens associated with different types of infection by serum antibody profiling.

Authors:  Jiin Felgner; Silvia Juarez; Chris Hung; L I Liang; Aarti Jain; Mert Döşkaya; Philip L Felgner; Ayşe Caner; Yüksel Gürüz; D Huw Davies
Journal:  Parasitology       Date:  2015-01-14       Impact factor: 3.234

4.  A comparative study of Toxoplasma gondii seroprevalence in three healthy Chinese populations detected using native and recombinant antigens.

Authors:  Xiaojing Sun; Huijun Lu; Boyin Jia; Zhiguang Chang; Shuai Peng; Jigang Yin; Qijun Chen; Ning Jiang
Journal:  Parasit Vectors       Date:  2013-08-20       Impact factor: 3.876

5.  Development of 116 kDa Fraction for Detecting Experimental Toxoplasma gondii Infections in Mice.

Authors:  Mohey Abdel-Hafez Hassanain; Eman Hussien Abdel-Rahman; Nagwa Ibrahim Toaleb; Raafat Mohamed Shaapan; Hasan Ali Elfadaly; Nawal Abdel-Hafez Hassanain
Journal:  Iran J Parasitol       Date:  2013-07       Impact factor: 1.012

6.  Molecular and serological detection of acute and latent toxoplasmosis using real-time PCR and ELISA techniques in blood donors of rafsanjan city, iran, 2013.

Authors:  Nahid Zainodini; Mohammad Zare-Bidaki; Seyyed Hossein Abdollahi; Mohammadreza Afrooz; Naser Ziaali; Mohammad Ebrahimian; Mohammad Kazemi Arababadi
Journal:  Iran J Parasitol       Date:  2014-09       Impact factor: 1.012

7.  Real-time RT-PCR on SAG1 and BAG1 gene expression during stage conversion in immunosuppressed mice infected with Toxoplasma gondii Tehran strain.

Authors:  Monavar Selseleh; Mohammad Hossein Modarressi; Mehdi Mohebali; Saeedeh Shojaee; Mohammad Reza Eshragian; Mina Selseleh; Ebrahim Azizi; Hossein Keshavarz
Journal:  Korean J Parasitol       Date:  2012-08-13       Impact factor: 1.341

8.  Brain Tissue Cysts in Infected Mice with RH-Strain of Toxoplasma gondii and Evaluation of BAG1 and SAG1 Genes Expression.

Authors:  Monavar Selseleh; Mh Modarressi; S Shojaee; M Mohebali; Mr Eshraghian; Mina Selseleh; H Keshavarz
Journal:  Iran J Parasitol       Date:  2013-01       Impact factor: 1.012

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.